Join Us, In Saving Lives And Engineering The Future
We are a diverse team of talented people who are dedicated to building technology that radically improves human lives.
January 20, 2022
jnani
Professor Florian Solzbacher, Co-Founder, Chairman, and President of Blackrock Neurotech discusses the MoveAgain Brain-Computer Interface (BCI) System that the FDA has granted a Breakthrough Device designation. It utilizes an array (electrode) implanted in the brain, which decodes intended movement from neuronal activity in the brain. This game-changing portable BCI offers patients new possibilities for movement and independence, reducing their reliance on caregivers and helping them better engage with society and the world. Blackrock has been leading the market for BCI technology for 15 years, with more humans implanted with Blackrock technology than any other BCI platform. Their aim is to commercially release the MoveAgain BCI system in 2022.